543 related articles for article (PubMed ID: 32459601)
1. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
Fujieda Y
Immunol Med; 2020 Dec; 43(4):135-141. PubMed ID: 32459601
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
3. [Neuropsychiatric manifestations in systemic lupus erythematosus].
Alexa ID; Stoica MS; Paraschiv O; Rusu RI
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):322-5. PubMed ID: 17802940
[TBL] [Abstract][Full Text] [Related]
4. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
Shimizu Y; Yasuda S; Kako Y; Nakagawa S; Kanda M; Hisada R; Ohmura K; Shimamura S; Shida H; Fujieda Y; Kato M; Oku K; Bohgaki T; Horita T; Kusumi I; Atsumi T
Autoimmun Rev; 2016 Aug; 15(8):786-94. PubMed ID: 27016478
[TBL] [Abstract][Full Text] [Related]
5. Juvenile Systemic Lupus Erythematosus: neuropsychiatric manifestations.
Fernandes H; Brito I
Acta Reumatol Port; 2012; 37(2):117-25. PubMed ID: 23149633
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
[TBL] [Abstract][Full Text] [Related]
7. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.
Magro-Checa C; Zirkzee EJ; Huizinga TW; Steup-Beekman GM
Drugs; 2016 Mar; 76(4):459-83. PubMed ID: 26809245
[TBL] [Abstract][Full Text] [Related]
8. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre.
Bortoluzzi A; Padovan M; Farina I; Galuppi E; De Leonardis F; Govoni M
Reumatismo; 2012 Dec; 64(6):350-9. PubMed ID: 23285478
[TBL] [Abstract][Full Text] [Related]
10. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
11. The role of B cells and autoantibodies in neuropsychiatric lupus.
Wen J; Stock AD; Chalmers SA; Putterman C
Autoimmun Rev; 2016 Sep; 15(9):890-5. PubMed ID: 27389531
[TBL] [Abstract][Full Text] [Related]
12. [Central neuropsychiatric involvement in systemic lupus erythematosus].
Madrane S; Ribi C
Rev Med Suisse; 2012 Apr; 8(337):848-53. PubMed ID: 22594009
[TBL] [Abstract][Full Text] [Related]
13. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.
Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
PLoS One; 2015; 10(3):e0119911. PubMed ID: 25781014
[TBL] [Abstract][Full Text] [Related]
14. Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus.
Shimojima Y; Matsuda M; Gono T; Ishii W; Ikeda S
Clin Rheumatol; 2005 Sep; 24(5):469-75. PubMed ID: 15742121
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.
Sciascia S; Bertolaccini ML; Roccatello D; Khamashta MA; Sanna G
J Neurol; 2014 Sep; 261(9):1706-14. PubMed ID: 24952022
[TBL] [Abstract][Full Text] [Related]
16. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
17. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
[TBL] [Abstract][Full Text] [Related]
18. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
[TBL] [Abstract][Full Text] [Related]
19. The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines.
Deijns SJ; Broen JCA; Kruyt ND; Schubart CD; Andreoli L; Tincani A; Limper M
Autoimmun Rev; 2020 Aug; 19(8):102592. PubMed ID: 32561462
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus.
Colasanti T; Delunardo F; Margutti P; Vacirca D; Piro E; Siracusano A; Ortona E
J Neuroimmunol; 2009 Jul; 212(1-2):3-9. PubMed ID: 19500858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
